HIGHLIGHTS
- who: Yong-Ping Lu from the Department of Nephrology, Center of Kidney and Urology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China have published the Article: SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease, in the Journal: (JOURNAL)
- what: This study demonstrated metabolic reprogramming in mice with DKD. This study was aimed to investigate the metabolic effects of SGLT2 inhibitors in DKD via liquid chromatography with tandem mass spectrometry (LC-MS/MS)based metabolomic and proteomic analyzes of serum and the kidneys, and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.